April 13- 16, 2026, Drug Discovery Chemistry

1) Novel Macrocyclic KIF18A Inhibitors for Treatment of Chromosomally Unstable Tumors: Discovery and Preclinical Characterization

 

2) Discovery and Optimization of a First-in-Class p300-Selective Oral Degrader Candidate